MAK CAPITAL ONE LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 76 filers reported holding RECRO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
MAK CAPITAL ONE LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2021$2,112,000
-38.2%
914,235
-25.3%
0.42%
-48.2%
Q1 2021$3,416,000
+41.0%
1,224,264
+44.0%
0.81%
+25.0%
Q4 2020$2,423,000
+62.3%
850,129
+19.6%
0.65%
+3.5%
Q3 2020$1,493,000
-67.3%
711,043
-29.2%
0.63%
-73.1%
Q2 2020$4,570,000
+44.0%
1,004,466
+158.6%
2.33%
-16.7%
Q1 2020$3,173,000388,4172.80%
Other shareholders
RECRO PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders